Nucleic Acids Research, 1993, Vol. 21, No. 23 5351-5359
© 1993
MOLECULAR BIOLOGY |
Identification of positive and negative regulatory elements involved in the retinoic acid/cAMP induction of Fgf-3 transcription in F9 cells
Imperial Cancer Research Fund Laboratories PO Box 123, 44 Lincoln's Inn Fields, London WC2A 3PX, UK
*To whom correspondence should be addressed
Received September 1, 1993. Revised October 11, 1993. Accepted October 11, 1993.
The proto-oncogene Fgf-3 has been implicated as an important signalling molecule in vertebrate development. In the mouse, it is expressed for a limited time at a multitude of sites from embryonic day 7 to birth. Transcription of Fgf-3 initiates at three promoter regions resulting in the generation of various mRNAs which nevertheless all encode the same protein products. A 1.7kb DNA fragment which encompasses these regions was joined to the CAT reporter gene and shown to function as a promoter in embryonal carcinoma cells. In stable transfectants the promoter retains its retinoic acid inducibility, initiating transcription at the same cap-sites as the endogenous gene. In differentiated F9 cells, transient transfection of progressive and targeted deletion mutants of the promoter region has revealed at least two positive and three negative regulatory elements. With one exception, loss of these elements was shown to dramatically affect promoter activity in stable transfectants of F9 cells. However the promoter remained inducible by retinoic acid to differing degrees, apart from deletions encompassing PS-4A which essentially abolished promoter activity in both undifferentiated and differentiated cells. The sequences of these potential regulatory regions were further defined using DNase-l footprinting, revealing some similarities to consensus binding sites for known transcription factors.
+Present address: Department de Genetica, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal, 08071 Barcelona, Spain
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Murakami, H. Shen, S. Ishida, and C. Dickson SOX7 and GATA-4 Are Competitive Activators of Fgf-3 Transcription J. Biol. Chem., July 2, 2004; 279(27): 28564 - 28573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Murakami, S. Ishida, and C. Dickson GATA-4 interacts distinctively with negative and positive regulatory elements in the Fgf-3 promoter Nucleic Acids Res., February 15, 2002; 30(4): 1056 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Murakami, S. Ishida, J. Thurlow, J.-M. Revest, and C. Dickson SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter Nucleic Acids Res., August 15, 2001; 29(16): 3347 - 3355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Antoine, M. Daum, R. Köhl, V. Blecken, M. J. Close, G. Peters, and P. Kiefer NH2-Terminal Cleavage of Xenopus Fibroblast Growth Factor 3 Is Necessary for Optimal Biological Activity and Receptor Binding Cell Growth Differ., November 1, 2000; 11(11): 593 - 605. [Abstract] [Full Text] |
||||
![]() |
M. L. Kingsley-Kallesen, D. Kelly, and A. Rizzino Transcriptional Regulation of the Transforming Growth Factor-beta 2 Promoter by cAMP-responsive Element-binding Protein (CREB) and Activating Transcription Factor-1 (ATF-1) Is Modulated by Protein Kinases and the Coactivators p300 and CREB-binding Protein J. Biol. Chem., November 26, 1999; 274(48): 34020 - 34028. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Murakami, J. Thurlow, and C. Dickson Retinoic Acid-regulated Expression of Fibroblast Growth Factor 3 Requires the Interaction between a Novel Transcription Factor and GATA-4 J. Biol. Chem., June 11, 1999; 274(24): 17242 - 17248. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Mak, S. Hoare, P. M. A. Henttu, and M. G. Parker Molecular Determinants of the Estrogen Receptor-Coactivator Interface Mol. Cell. Biol., May 1, 1999; 19(5): 3895 - 3903. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Galdemard, H. Yamagata, O. Brison, and C. Lavialle Regulation of FGF-3 Gene Expression in Tumorigenic and Non-tumorigenic Clones of a Human Colon Carcinoma Cell Line J. Biol. Chem., June 2, 2000; 275(23): 17364 - 17373. [Abstract] [Full Text] [PDF] |
||||



